Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Cell And Gene Therapy Supply Chain/Logistics Market Size Forecast: How Large Could The Market Become By 2030?
The market for cell and gene therapy supply chain and logistics has experienced substantial expansion. Projections indicate a rise from $1.58 billion in 2025 to $1.78 billion in 2026, reflecting a compound annual growth rate of 12.2%. This trajectory of growth during the preceding period was influenced by several key factors: the escalating intricacy of transporting cell and gene therapies, the early embrace of cold chain shipping technologies, the proliferation of centralized production facilities, a heightened regulatory emphasis on tracking and tracing, and the increasing engagement of dedicated logistics companies.
The market for cell and gene therapy supply chain and logistics is poised for substantial expansion in the coming years, anticipating a surge to $2.81 billion by 2030, fueled by a compound annual growth rate (CAGR) of 12.1%. This projected surge is largely due to the increasing commercialization of individualized treatments, a heightened need for comprehensive supply chain visibility, the widening of worldwide therapy distribution networks, greater utilization of cloud-based logistics solutions, and significant investments in advanced cold chain infrastructure. Key developments anticipated during this forecast period encompass the proliferation of unified cold chain management systems, increased implementation of real-time tracking and traceability technologies, a greater reliance on cryogenic logistics services, deeper integration of patient-focused supply chain frameworks, and an intensified commitment to ensuring chain of custody adherence.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp
Cell And Gene Therapy Supply Chain/Logistics Market Development Factors: Which Trends Are Supporting Demand?
The expanding demand for sophisticated cell and gene therapies is acting as a catalyst for the growth of the cell and gene therapy supply chain and logistics sector. These cutting-edge medical approaches, which involve altered cells or genes to combat illnesses, hold immense promise for conditions previously considered incurable. Ensuring the integrity of these therapies necessitates precise temperature and storage management throughout their journey, a task expertly handled by specialized supply chain and logistics providers who oversee everything from procurement to final delivery and warehousing. A significant indicator of this trend is the reported 10% surge in gene therapies advancing to Phase III clinical trials in the third quarter of 2023, marking the first quarterly upturn since Q3 2022, according to data from the American Society of Gene & Cell Therapy. Consequently, the escalating requirements of cell and gene therapies are fueling the expansion of the associated supply chain and logistics market.
#Cell And Gene Therapy Supply Chain/Logistics Market Segment Landscape And Growth Potential
The cell and gene therapy supply chain/logistics market covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
Subsegments:
1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking, Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation
Cell And Gene Therapy Supply Chain/Logistics Market Transformation Trends: Which Innovations Are Driving Change?
The adoption of advanced technology platforms is a significant and growing phenomenon within the cell and gene therapy supply chain and logistics sectors. Leading organizations in this field are actively creating and implementing these cutting-edge platforms as a strategy to solidify their market standing. As an illustration, in April 2023, US-based healthcare firm AmerisourceBergen Corporation, which focuses on the logistics of cell and gene therapy supply chains, introduced its Cell and Gene Therapy (CGT) Integration Hub. This innovative hub leverages AmerisourceBergen’s proprietary customer relationship management (CRM) system and is designed for seamless integration with biopharmaceutical platforms, thereby enhancing the oversight of both the development and distribution processes for cell and gene therapies.
Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the cell and gene therapy supply chain/logistics market are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.
Access The Complete Cell And Gene Therapy Supply Chain/Logistics Market Report:
Cell And Gene Therapy Supply Chain/Logistics Market Regional Distribution: Which Areas Drive Market Expansion?
North Americawas the largest region in the cell and gene therapy supply chain/logistics market in 2025. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
